Title of article
Clinical Decision Support and New Regulatory Frameworks for Medical Devices: Are We Ready for It? - A Viewpoint Paper
Author/Authors
Van Laere ، Sven Research Group of Biostatistics and Medical Informatics (BISI), Department of Public Health (GEWE) - Vrije Universiteit Brussel , Muylle ، Katoo Research Group Clinical Pharmacology and Clinical Pharmacy (KFAR) - Centre for Pharmaceutical Research (CePhar) - Vrije Universiteit Brussel , Cornu ، Pieter Research Group Clinical Pharmacology and Clinical Pharmacy (KFAR) - Centre for Pharmaceutical Research (CePhar) - Vrije Universiteit Brussel
From page
3159
To page
3163
Abstract
This commentary reflects on an important article by Fisher and colleagues who draw on four Australian policy case studies to examine how universal and targeted approaches or a combination can be deployed to improve health equity. They conclude that universal approaches are central to action to increase health equity, but that targeting can improve equity of access in some situations including in the context of proportionate universalism. However, we argue that although target services may provide benefits for some populations, they are often stigmatizing and fail to reach may people they aim to support. Instead of accepting the dominant discourse about the key role for targeted approaches, we argue that those committed to reduce social and health inequities should consider the potential of Equity Sensitive Universalism (ESU). This approach focuses on achieving proportionate outcomes with equally provided resources rather than proportionate inputs and provides a ‘cohesion dividend,’ increasing social solidarity.
Keywords
Health Policy , Medical Device Regulation , Medical Device Software , Clinical Decision Support , Cures Act
Journal title
International Journal of Health Policy and Management(IJHPM)
Journal title
International Journal of Health Policy and Management(IJHPM)
Record number
2770499
Link To Document